We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug & Device Products
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Publications
    • Webinar Training Pass
    • eCFR and Guidances
    • Books
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Store » Medical Devices » Breakthrough Medical Devices – Webinar Recording/Transcript

Other Options

Webinar Recording & Transcript Bundle - Nov. 16, 2020

$287.00

Webinar Recording & Transcript Bundle - Nov. 16, 2020

$258.00

Webinar Recording & Transcript Bundle - Nov. 16, 2020

$244.00

Webinar Recording & Transcript Bundle - Nov. 16, 2020

$230.00

Webinar Recording & Transcript Bundle - Nov. 16, 2020

$215.00
Evan Phelps -Teal

Breakthrough Medical Devices – Webinar Recording/Transcript

$287.00
Medical Devices

Product Details

In the past, it’s been difficult to get marketing authorization from the FDA for novel medical device technologies — and even if those authorizations were made, it could take years for a Centers for Medicare and Medicaid Services (CMS) coverage decision. Not anymore.

With the Breakthrough Device Program, critically ill patients can get quicker access to these devices. Additionally, CMS has published a proposed rule to allow for Medicare coverage the same day some of these devices receive 510(k) clearance.

This Breakthrough Medical Devices webinar on Nov. 16 will cover the details of how to use this new program to your advantage, including what it takes to be designated as a breakthrough device and the scope of the CMS reimbursement strategies. Through our expert advice, you’ll discover how to navigate this helpful and profitable policy.

Evan Phelps, Partner at Amin Talati Wasserman, LLP, will share the most significant issues that could arise when implementing the FDA guidance on breakthrough devices. He’ll discuss petition requirements, FDA criteria for selection and proposed indications for use.

During this webinar, we’ll cover:

  • The basics of the FDA’s Breakthrough Device Program

  • Program benefits and how the designation will push a device to market earlier

  • Application requirements for a breakthrough device designation, including description of use, proposed indication for use and regulation history

  • FDA criteria to identify breakthrough devices, including specific statutory criteria from Appendix I of the Breakthrough Devices Program Final Guidance

  • Key elements the FDA uses to review breakthrough device applications

  • Expectations around the proposed CMS Breakthrough Device reimbursement rule

With the FDA’s Breakthrough Device Program, you and your team can gain approval and begin marketing your novel medical device faster. Join us by registering now.

Meet Your Instructor

Evan Phelps, partner at Amin Talati Wasserman, LLP, specializes in medical device law and has been advising and representing companies before the FDA for nearly 20 years. His experience spans the breadth of the FDA’s medical device regulatory requirements. He has helped clients obtain marketing authorizations, comply with ongoing regulatory controls and avoid or address the aftermath of an FDA enforcement action.

Who Will Benefit

  • Medical device manufacturers
  • Medical technology development firms
  • Medical technology start-up companies
  • Teams developing marketing plans for medical devices
  • Manufacturers of novel medical technologies that do not fit neatly into the FDA’s established device approval process
  • Teams searching for reimbursement strategies
  • Quality professionals
  • Regulatory affairs professionals
  • QSR professionals
  • Post-market safety teams
  • Submissions and approvals teams
  • Research and development staff
  • Commercial operations staff

Webinar Recording & Transcript Bundle

$287.00
Add to Cart

Webinar date:
Nov. 16, 2020

  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell or Share My Data
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Toll free 888.838.5578

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing